Ruigang Xu

576 citations
22 papers · 361 indexed · h-index 14
Topics
Asymmetric Synthesis and Catalysis (6 papers)Catalytic C–H Functionalization Methods (5 papers)Platelet Disorders and Treatments (5 papers)

In The Last Decade

Ruigang Xu

21 papers receiving 359 citations

Peers

Ruigang Xu
Comparison fields: 5 of 68
  • Organic Chemistry 169
  • Molecular Biology 72
  • Hematology 61
  • Ecology 57
  • Cardiology and Cardiovascular Medicine 39
Replace Christopher M. Williams with:
Christopher M. Williams United Kingdom
Mallikarjun Sundaram United States
Fan Ma China
Sarah N. McCurdy United States
Fabian Tölle Germany
Kaoru Fujii Japan
John F. Harwig United States
Alexander R. Mukhitov Russia
Anne-Sofie Carlström Sweden
Leslie Naranjo United States
Ruigang Xu relative to Christopher M. Williams United Kingdom Christopher M. Williams's profile →
Citations per field
00.5×11.4×
Christopher M. Williams · 1×
Citations per year

Countries citing papers authored by Ruigang Xu

Since Specialization
Citations

This map shows the geographic impact of Ruigang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruigang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruigang Xu more than expected).

Fields of papers citing papers by Ruigang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruigang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruigang Xu. The network helps show where Ruigang Xu may publish in the future.

Co-authorship network of co-authors of Ruigang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruigang Xu. A scholar is included among the top collaborators of Ruigang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruigang Xu. Ruigang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 18
4 2
5 6
6 1
7 26
8 15
9 14
10 14
11 22
12 24
13 14
14 13
15 32
16 17
17 37
18 17
19 5
20 1

About Ruigang Xu

Ruigang Xu is a scholar working on Hematology, Virology and Organic Chemistry, having authored 22 papers that have together received 361 indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (6 papers), Catalytic C–H Functionalization Methods (5 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Organic Chemistry (169 citations), Hematology (61 citations) and Internal Medicine (20 citations). Ruigang Xu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Guofu Zhong, Xiaofei Zeng, Shulei Pan, Min Jiang, Robert A.S. Ariëns, Julia S. Gauer, Steve P. Watson, Brian A. Kelch, Nicholas P. Stone and Brendan J. Hilbert. Their work appears in journals such as Nucleic Acids Research, Chemical Communications and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026